Tanshinone IIA is the phenanthrenequinone derivative extracted from the perennial plant Salvia miltiorrhiza Bunge (red sage). We investigated whether inhibition of the nucleotide-binding oligomerization domain (NOD)-like receptor family protein 3 (NLRP3) inflammasome mediates the protective effect of tanshinone IIA in acute lung injury (ALI) induced in rats by oleic acid (OA) injection. Compared with the control treatment, OA injection induced pulmonary histological impairment, increased the lung wet/dry weight ratio (7.0±1.1 vs 4.3±0.6) and CO 2 partial pressure (PaCO 2) (52±6.4 vs 40±3.6 mmHg), decreased arterial O 2 partial pressure (PaO 2) (63±8.4 vs 100±3.0 mmHg), and increased tumor necrosis factor α (TNFα) (8.8±2.3 vs 5.2±1.5 pg/mL), monocyte chemoattractant protein-1 (MCP-1) (36.1±4.9 vs 25.2±6.6 pg/mL) and interleukin-1β (IL-1β) (15.9±3.2 vs 4.6±1.3 pg/mL) in the bronchoalveolar lavage (BAL) fluid. Tanshinone IIA provided protection against ALI, observed as a reduction in the lung wet/dry weight ratio and CO 2 partial pressure, and increased O 2 partial pressure. The cytokine increase was also prevented. Tanshinone IIA attenuated increased protein levels of NLRP3, caspase-1 and IL-1β in pulmonary tissues, suggesting that it ameliorates ALI by preventing NLRP3 inflammasome activation.